1. Dis Markers. 2015;2015:460974. doi: 10.1155/2015/460974. Epub 2015 Feb 19.

The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in 
Mexican population.

García-González IJ(1), Valle Y(2), Sandoval-Pinto E(3), Valdés-Alvarado E(3), 
Valdez-Haro A(1), Muñoz-Valle JF(2), Flores-Salinas HE(4), Figuera-Villanueva 
LE(5), Dávalos-Rodríguez NO(6), Padilla-Gutiérrez JR(2).

Author information:
(1)Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de 
Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, Mexico 
; Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 
44350 Guadalajara, JAL, Mexico.
(2)Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de 
Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, 
Mexico.
(3)Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 
44350 Guadalajara, JAL, Mexico.
(4)Centro Médico Nacional de Occidente, IMSS, 44350 Guadalajara, JAL, Mexico.
(5)Centro de Investigación Biomédica de Occidente, IMSS, 44350 Guadalajara, JAL, 
Mexico.
(6)Instituto de Investigación en Genética Humana, Centro Universitario de 
Ciencias de la Salud, Universidad de Guadalajara, 44350 Guadalajara, JAL, 
Mexico.

BACKGROUND: Acute coronary syndrome (ACS) has an important impact in public 
health with high morbidity and mortality. Prothrombotic and proinflammatory 
states are involved in the pathogenesis of the disease. Plasminogen activator 
inhibitor-1 (PAI-1) is the major inhibitor of the fibrinolysis and also is part 
of immune response. The -844 G>A gene polymorphism is related to increased PAI-1 
protein levels. The aim of the study is to evaluate the association of -844 G>A 
PAI-1 polymorphism with ACS.
METHODS: A total of 646 individuals were recruited from Western Mexico: 350 
unrelated healthy subjects and 296 patients with diagnosis of ACS.
RESULTS: The most important risk factor in our population was hypertension, 
followed by smoking. The genetic distribution showed an association of the A 
allele (OR = 1.27, P = 0.04) and AA genotype (OR = 1.86, P = 0.02) with ACS. The 
recessive model displayed similar results (OR = 1.76, P = 0.02). As additional 
finding, we observed significant differences in the genetic distribution of ACS 
dyslipidemic patients (OR = 1.99, P = 0.04). The A allele and AA genotype of 
-844 polymorphism of PAI-1 gene are risk factors for ACS. The AA genotype might 
be associated with the development of dyslipidemia in ACS patients.

DOI: 10.1155/2015/460974
PMCID: PMC4350946
PMID: 25788758 [Indexed for MEDLINE]